companydata.dkAktieselskabet af 16. februar 2024: Financial statements 2014
CVR: 33034911
Aktieselskabet af 16. februar 2024 (CVR 33034911) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 13,664,079 and a net result of DKK 3,188,334 compared with DKK 1,538,179 the year before. That is an increase of 38.8% compared with the year before. Equity amounted to DKK 3,715,341. The solvency ratio was 31.7%.
- Gross Profit
- 13,664,079 kr.
- Profit/Loss
- 3,188,334 kr.
- Equity
- 3,715,341 kr.
- Total Assets
- 11,728,384 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 13.7 mio. | 3.2 mio. | 3.7 mio. | - |
| 2013 | - | 9.8 mio. | 1.5 mio. | 527 t. | - |
Keep an eye on Aktieselskabet af 16. februar 2024
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
Aktieselskabet af 16. februar 2024 has published its annual report for 2013. Gross profit came to DKK 9,843,893, and the net result was DKK 1,538,179.
About Aktieselskabet af 16. februar 2024
Aktieselskabet af 16. februar 2024 was a Danish company of the type Aktieselskab based in København K, founded in 2010. The company was registered under the industry Speciallægers aktiviteter. The company was previously named TFP Stork Fertility A/S and STORK IVF KLINIK A/S. The company is owned by VivaNeo DK ApS. The company has 54 employees. In 2023, the company reported a gross profit of DKK 14,491,315 and a net result of DKK -13,702,784 compared with DKK -8,491,214 the year before. Equity amounted to DKK -27,031,558.